((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy)acetic acid, (+)- → 2-Butyl-6,7-dichloro-2-cyclopentyl-5-hydroxy-1-indanone
반응식
[CH2:1]([C:5]1([CH:22]2[CH2:26][CH2:25][CH2:24][CH2:23]2)[CH2:13][C:12]2[C:7](=[C:8]([Cl:20])[C:9]([Cl:19])=[C:10]([O:14]CC(O)=O)[CH:11]=2)[C:6]1=[O:21])[CH2:2][CH2:3][CH3:4]>C(O)(=O)C>[CH2:1]([C:5]1([CH:22]2[CH2:26][CH2:25][CH2:24][CH2:23]2)[CH2:13][C:12]2[C:7](=[C:8]([Cl:20])[C:9]([Cl:19])=[C:10]([OH:14])[CH:11]=2)[C:6]1=[O:21])[CH2:2][CH2:3][CH3:4]참가 물질
3
실험 절차
By following substantially the procedure in Example 8, Step A, but substituting for (+) 6,7-dichloro-2-cyclopentyl-2,3-dihydro-2-methyl-1-oxo-1H-inden-5-yl)oxy]acetic acid an equimolar quantity of (-) [(2-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy]acetic acid, there is obtained (-) 2-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-5-hydroxy-1H-inden-1-one which is used in Step C without further purification.
출처 및 근거
- ORD 기록